Evidence map›Paper›PMID 40495969›Full record

ArticleFrontiers in medicine2025

Evaluating the impact of Age-Adjusted Charlson Comorbidity Index on in-hospital complications in patients with femoral fracture: a retrospective cohort analysis from the MIMIC-IV 2.2 database.

Ping Xu, Liping Wang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ping XuDepartment of Osteology, Shaoxing Second Hospital, Shaoxing, Zhejiang, China.
Liping WangDepartment of Osteology, Shaoxing Second Hospital, Shaoxing, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Femoral fractures in hospitalized patients often lead to limited mobility, increasing the risk of complications like deep venous thrombosis (DVT), pressure ulcers, and delirium. These risks are particularly pronounced in elderly patients with multiple comorbidities. Monitoring such patients using reliable indices like the Age-Adjusted Charlson Comorbidity Index (ACCI) can help in early identification and management of these risks. This study investigates the association between ACCI scores and the incidence of in-hospital complications DVT, pressure ulcers, delirium in patients with femoral fractures. Methods: Using the MIMIC-IV 2.2 database, we extracted data for 4,134 patients diagnosed with femoral fractures after applying exclusion criteria such as repeated admissions, age under 18, and significant missing data. ACCI and other demographic and clinical data were used in logistic regression models and restricted cubic spline (RCS) analyses to assess the relationship between ACCI and complication risks. Results: A nonlinear association between ACCI and complication risk was identified, with significant risk increases beyond an ACCI of 5. Patients were divided into low-ACCI (≤5) and high-ACCI (>5) groups. High-ACCI patients had significantly greater risks of developing DVT (OR = 2.151), pressure ulcers (OR = 2.168), and delirium (OR = 1.791), compared to low-ACCI patients, indicating ACCI's effectiveness in predicting these complications. Conclusion: ACCI is a valuable tool for predicting the risk of in-hospital complications among femoral fracture patients, facilitating targeted interventions and improved patient management.

Indexed as

Age-Adjusted Charlson Comorbidity Indexdeep venous thrombosisdeliriumfemoral fracturepressure ulcers

Identifiers

PMID40495969
PMCPMC12149143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.